Bank Of Montreal Albireo Pharma, Inc. Transaction History

Bank Of Montreal

  • $214 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$21.19 - $31.29 $623,303 - $920,395
-29,415 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$27.36 - $35.98 $21,477 - $28,244
-785 Reduced 2.6%
29,415 $957,000
Q2 2021

Aug 12, 2021
BUY
$28.9 - $36.87 $872,780 - $1.11 Million
30,200 New
30,200 $1.11 Million

Others Institutions Holding ALBO

# of Institutions
4
Shares Held
865
Call Options Held
0
Put Options Held
0
View Full List

About ALBIREO PHARMA, INC.

ALBO Quotes by TradingView
  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email